Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Autoimmune Disorders

Free Subscription 07.11.2022 3 BMC Neurol 2 Brain 7 Diabetes Res Clin Pract 1 Intern Med 1 J Immunol 1 J Neuroimmunol 3 J Neurol 3 J Pediatr Endocrinol Metab 4 J Rheumatol 1 Kidney Int 1 Lancet 1 Mult Scler 1 N Engl J Med 3 Nat Rev Neurol 6 Neurology 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. JIN Y, Chu H, Dong H, Wang H, et al
   Chronic inflammatory demyelinating polyneuropathy and psoriasis comorbidity with significantly alleviated in symptoms after secukinumab: case report.
   BMC Neurol. 2022;22:400.
   PubMed         Abstract available
   
   
2. POLILLI E, Frattari A, Esposito JE, Angelini G, et al
   SOX-1 antibodies in a patient with Crohn's disease: a case report.
   BMC Neurol. 2022;22:404.
   PubMed         Abstract available
   
   
3. ALI ASHRAFI S, Asadi M, Shanehbandi D, Sadigh Eteghad S, et al
   Association between miRNA-145 and miRNA-155 expression in peripheral blood mononuclear cells of patients with multiple sclerosis: a case-control study.
   BMC Neurol. 2022;22:405.
   PubMed         Abstract available
   
   

   
   Brain

4. GARTON T, Gill AJ, Calabresi PA
   Distinct mechanisms of oligodendrocyte injury inform therapeutic interventions in multiple sclerosis.
   Brain. 2022 Nov 3. pii: 6794531. doi: 10.1093.
   PubMed        
   
   
5. ROSTGAARD K, Nielsen NM, Melbye M, Frisch M, et al
   Siblings reduce multiple sclerosis risk by preventing delayed primary Epstein-Barr virus infection.
   Brain. 2022 Nov 1. pii: 6783238. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

6. ELEDRISI MS, Alkabbani H, Aboawon M, Ali A, et al
   Clinical characteristics and outcomes of care in patients hospitalized with diabetic ketoacidosis.
   Diabetes Res Clin Pract. 2022;192:110041.
   PubMed         Abstract available
   
   
7. BOZZETTO L, Pacella D, Cavagnuolo L, Capuano M, et al
   Postprandial glucose variability in type 1 diabetes: The individual matters beyond the meal.
   Diabetes Res Clin Pract. 2022;192:110089.
   PubMed         Abstract available
   
   
8. LIMBERT C, Lanzinger S, deBeaufort C, Iotova V, et al
   Diabetes-related antibody-testing is a valuable screening tool for identifying monogenic diabetes - A survey from the worldwide SWEET registry.
   Diabetes Res Clin Pract. 2022;192:110110.
   PubMed         Abstract available
   
   
9. NEJATIAN MM, Lan NSR, Yeap BB, Dwivedi G, et al
   Characteristics and outcomes of patients with type 1 diabetes admitted with acute coronary syndromes.
   Diabetes Res Clin Pract. 2022;192:110093.
   PubMed         Abstract available
   
   
10. TILDEN DR, French B, Shoemaker AH, Corathers S, et al
    Prolonged lapses between pediatric and adult care are associated with rise in HbA1c and inpatient days among patients with type 1 diabetes.
    Diabetes Res Clin Pract. 2022;192:110113.
    PubMed         Abstract available
    
    
11. EZENWAKA CE
    A cross-talk between perceptions and reality on insulin therapy among Type-2 diabetes patients in developing countries.
    Diabetes Res Clin Pract. 2022;192:110114.
    PubMed        
    
    
12. 
    New global Type 1 Diabetes Index highlights the unmet need of people living with type 1 diabetes.
    Diabetes Res Clin Pract. 2022;192:110123.
    PubMed        
    
    

    
    Intern Med

13. IMAIZUMI C, Ogura T, Inoue Y, Takakura Y, et al
    Reduced Rate of Disease Flares in Japanese Patients with Systemic Lupus Erythematosus: An Altered Balance between the Use of Glucocorticoids and Immunosuppressants in Recent Decades.
    Intern Med. 2022;61:3189-3196.
    PubMed         Abstract available
    
    

    
    J Immunol

14. MURATA R, Kinoshita S, Matsuda K, Kawaguchi A, et al
    G307S DNAM-1 Mutation Exacerbates Autoimmune Encephalomyelitis via Enhancing CD4(+) T Cell Activation.
    J Immunol. 2022 Nov 2. pii: jimmunol.2200608. doi: 10.4049/jimmunol.2200608.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

15. LI X, Chu Y, Ma R, Dou M, et al
    Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2022;373:577995.
    PubMed         Abstract available
    
    

    
    J Neurol

16. MOCCIA M, Affinito G, Berera G, Marrazzo G, et al
    Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy.
    J Neurol. 2022;269:6504-6511.
    PubMed         Abstract available
    
    
17. PAKEERATHAN T, Havla J, Schwake C, Salmen A, et al
    Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode.
    J Neurol. 2022;269:6366-6376.
    PubMed         Abstract available
    
    
18. OMARY R, Bockisch CJ, De Vere-Tyndall A, Pazahr S, et al
    Lesion follows function: video-oculography compared with MRI to diagnose internuclear ophthalmoplegia in patients with multiple sclerosis.
    J Neurol. 2022 Oct 31. pii: 10.1007/s00415-022-11428.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

19. SENBANJO IO, Akinola IJ, Umar UI, Anyabolu CH, et al
    Children and adolescents with type 1 diabetes mellitus in Nigeria: clinical characteristics and compliance with care.
    J Pediatr Endocrinol Metab. 2022;35:1377-1384.
    PubMed         Abstract available
    
    
20. ELHABASHY SA, Abd ElMalak MW, Elrassas HH, Thabet RA, et al
    Disordered eating and behaviors among young Egyptians with type 1 diabetes: risk factors and comorbidities.
    J Pediatr Endocrinol Metab. 2022;35:1385-1393.
    PubMed         Abstract available
    
    
21. SOBU E, Yildiz Z
    Does cystatin C have an immunomodulatory role in Hashimoto's thyroiditis?
    J Pediatr Endocrinol Metab. 2022 Nov 4. pii: jpem-2022-0386.
    PubMed         Abstract available
    
    

    
    J Rheumatol

22. YOSHINARI M, Hattanda F, Nishibata Y, Masuda S, et al
    A Novel Antineutrophil Extracellular Trap Antibody Targeting Myosin Light Chain 6 in Microscopic Polyangiitis.
    J Rheumatol. 2022;49:1286-1288.
    PubMed        
    
    
23. JOHNSON SR, Martinez JPD, Whittall-Garcia L, Urowitz MB, et al
    Evaluating the threshold score for classification of systemic lupus erythematosus using the EULAR/ACR criteria.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220100. doi: 10.3899/jrheum.220100.
    PubMed         Abstract available
    
    
24. ZHUO N, Wang G, Li J, Liu Y, et al
    Systemic Lupus Erythematosus Flares During Dialysis in Patients With Endstage Renal Disease.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220947. doi: 10.3899/jrheum.220947.
    PubMed         Abstract available
    
    
25. SEO P, Winthrop K, Sawalha AH, Choi S, et al
    Physicians' perspective on vaccination in patients with autoimmune inflammatory rheumatic diseases: an international survey.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220135. doi: 10.3899/jrheum.220135.
    PubMed         Abstract available
    
    

    
    Kidney Int

26. SHIM JS, Kim EJ, Lee LE, Kim JY, et al
    The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosus.
    Kidney Int. 2022 Nov 1. pii: S0085-2538(22)00913.
    PubMed         Abstract available
    
    

    
    Lancet

27. WIECH T, Reinhard L, Wulf S, Giuffrida AE, et al
    Bacterial infection possibly causing autoimmunity: Tropheryma whipplei and membranous nephropathy.
    Lancet. 2022 Oct 31. pii: S0140-6736(22)02039.
    PubMed        
    
    

    
    Mult Scler

28. VUKUSIC S, Carra-Dalliere C, Ciron J, Maillart E, et al
    Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society.
    Mult Scler. 2022 Nov 1:13524585221129472. doi: 10.1177/13524585221129472.
    PubMed         Abstract available
    
    

    
    N Engl J Med

29. BRENNAN T
    Pharmaceutical Marketing Revisited - United States v. Biogen Idec.
    N Engl J Med. 2022;387:1631-1633.
    PubMed        
    
    

    
    Nat Rev Neurol

30. LEMPRIERE S
    FDA-approved drug promotes remyelination.
    Nat Rev Neurol. 2022;18:637.
    PubMed        
    
    
31. LEMPRIERE S
    Brain volume is associated with cognition in MS.
    Nat Rev Neurol. 2022;18:637.
    PubMed        
    
    
32. KIANI L
    No seasonality in multiple sclerosis risk near the Equator.
    Nat Rev Neurol. 2022 Nov 1. pii: 10.1038/s41582-022-00743.
    PubMed        
    
    

    
    Neurology

33. LEWIS A, Galetta S
    Editors' Note: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Neurology. 2022;99:818.
    PubMed        
    
    
34. BEBO BF
    Author Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Neurology. 2022;99:819.
    PubMed        
    
    
35. VARGAS WS
    Reader Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Neurology. 2022;99:818-819.
    PubMed        
    
    
36. LI L, Avina-Zubieta JA, Bernstein CN, Kaplan GG, et al
    Risk of Multiple Sclerosis Among Users of Antitumor Necrosis Factor Alpha in Four Canadian Provinces: A Population-Based Study.
    Neurology. 2022 Oct 28. pii: WNL.0000000000201472.
    PubMed         Abstract available
    
    
37. 
    Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
    Neurology. 2022 Oct 28. pii: WNL.0000000000201391.
    PubMed        
    
    
38. STRIJBIS EMM, Koch MW
    TNF Alfa Blockers and the Risk of Multiple Sclerosis.
    Neurology. 2022 Oct 28. pii: WNL.0000000000201629.
    PubMed        
    
    

    
    PLoS One

39. GRANLUND L, Hedin A, Korsgren O, Skog O, et al
    Altered microvasculature in pancreatic islets from subjects with type 1 diabetes.
    PLoS One. 2022;17:e0276942.
    PubMed         Abstract available
    
    
40. AMATYA M, Pant AD
    Clinical and histopathological study of renal biopsy in Nepalese children: A single center experience.
    PLoS One. 2022;17:e0276172.
    PubMed         Abstract available
    
    
41. DAVID BL, Ivan GJ, Emilio PE, Daniela MJ, et al
    Low serum uromodulin levels and their association with lupus flares.
    PLoS One. 2022;17:e0276481.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: